Calavo Growers (CVGW) Financials

$26.52 +0.94 (+3.67%)

Closing price 05/27/2025 04:00 PM Eastern

Extended Trading

$26.41 -0.11 (-0.41%)

As of 05/27/2025 07:59 PM Eastern

Annual Income Statements for Calavo Growers

This table shows Calavo Growers' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	10/31/2024	10/31/2023	10/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-1.08	-8.34	-6.25
Consolidated Net Income / (Loss)	-1.02	-7.97	-6.60
Net Income / (Loss) Continuing Operations	6.85	5.05	-6.85
Total Pre-Tax Income	9.65	12	-3.12
Total Operating Income	17	12	6.79
Total Gross Profit	68	63	55
Total Revenue	662	594	770
Operating Revenue	662	594	770
Total Cost of Revenue	594	531	715
Operating Cost of Revenue	594	531	715
Total Operating Expenses	51	50	48
Selling, General & Admin Expense	50	47	47
Other Special Charges / (Income)	1.04	3.13	1.42
Total Other Income / (Expense), net	-7.07	-0.13	-9.91
Interest Expense	2.89	2.37	1.63
Interest & Investment Income	1.02	0.61	0.50
Other Income / (Expense), net	-5.20	1.64	-8.78
Income Tax Expense	2.33	6.15	3.17
Other Gains / (Losses), net	-0.48	-0.88	-0.56
Net Income / (Loss) Discontinued Operations	-7.87	-13	0.25
Net Income / (Loss) Attributable to Noncontrolling Interest	0.05	0.38	-0.35
Basic Earnings per Share	($0.06)	($0.47)	($0.35)
Weighted Average Basic Shares Outstanding	17.80M	17.75M	17.66M
Diluted Earnings per Share	($0.06)	($0.47)	($0.35)
Weighted Average Diluted Shares Outstanding	17.86M	17.85M	17.75M
Weighted Average Basic & Diluted Shares Outstanding	17.84M	17.80M	17.73M

This table shows Calavo Growers' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Income / (Loss) Attributable to Common Shareholders	4.42	-0.14	-0.73	6.06	-6.27	-7.91	6.63	-4.00	-3.07	-3.32	1.30
Consolidated Net Income / (Loss)	4.44	-0.10	-0.76	6.10	-6.26	-7.92	6.71	-3.96	-2.80	-3.48	1.32
Net Income / (Loss) Continuing Operations	4.44	-2.45	5.37	6.51	-2.57	-4.69	8.74	1.45	-0.45	-3.73	1.32
Total Pre-Tax Income	4.83	0.46	4.50	6.69	-2.00	-0.91	12	1.99	-0.64	-0.45	2.57
Total Operating Income	5.05	1.61	9.36	7.14	-3.09	0.68	10	1.92	-0.61	3.82	1.55
Total Gross Profit	16	15	20	20	11	12	22	16	13	1.26	19
Total Revenue	154	170	180	184	128	142	161	158	133	-178	342
Operating Revenue	154	170	180	184	128	142	161	158	133	-178	342
Total Cost of Revenue	139	155	160	164	117	130	139	143	120	-179	323
Operating Cost of Revenue	139	155	160	164	117	130	139	143	120	-179	323
Total Operating Expenses	11	13	11	13	14	11	12	14	14	-2.56	17
Selling, General & Admin Expense	10	13	11	13	13	9.28	13	13	12	-1.96	17
Other Special Charges / (Income)	0.40	-	-	0.20	0.38	1.90	-1.20	0.39	2.05	0.27	0.30
Total Other Income / (Expense), net	-0.22	-1.15	-4.86	-0.44	1.08	-1.58	1.43	0.06	-0.04	-4.26	1.02
Interest Expense	0.21	0.27	0.83	0.96	0.82	0.98	0.77	0.24	0.38	0.36	0.49
Interest & Investment Income	0.85	-	-	-	0.00	-	-	-	-	-	-
Other Income / (Expense), net	-0.85	-1.90	-4.02	0.52	1.91	-1.21	2.20	0.31	0.34	-4.41	1.50
Income Tax Expense	1.26	2.80	-1.44	0.39	0.57	3.30	2.41	0.48	-0.04	3.53	0.98
Other Gains / (Losses), net	0.86	-0.10	-0.58	0.20	0.00	-0.48	-0.50	-0.06	0.16	0.25	-0.27
Net Income / (Loss) Discontinued Operations	0.00	2.35	-6.13	-0.41	-3.68	-3.23	-2.03	-5.41	-2.35	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	0.02	0.04	-0.03	0.04	0.01	-0.01	0.08	0.04	0.27	-0.17	0.02
Basic Earnings per Share	$0.25	($0.01)	($0.04)	$0.34	($0.35)	($0.44)	$0.37	($0.23)	($0.17)	($0.18)	$0.07
Weighted Average Basic Shares Outstanding	17.84M	17.80M	17.80M	17.80M	17.80M	17.75M	17.76M	17.72M	17.67M	17.66M	17.67M
Diluted Earnings per Share	$0.25	($0.01)	($0.04)	$0.34	($0.35)	($0.44)	$0.37	($0.23)	($0.17)	($0.18)	$0.07
Weighted Average Diluted Shares Outstanding	17.90M	17.86M	17.84M	17.87M	17.80M	17.85M	17.86M	17.88M	17.67M	17.75M	17.77M
Weighted Average Basic & Diluted Shares Outstanding	17.84M	17.84M	17.80M	17.80M	17.80M	17.80M	17.76M	17.78M	17.74M	17.73M	17.73M
Cash Dividends to Common per Share	$0.10	-	$0.10	$0.10	$0.10	-	$0.10	$0.10	$0.29	-	-

This table details how cash moves in and out of Calavo Growers' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	10/31/2024	10/31/2023	10/31/2022
Net Change in Cash & Equivalents	54	-0.28	0.28
Net Cash From Operating Activities	24	-14	50
Net Cash From Continuing Operating Activities	24	-14	50
Net Income / (Loss) Continuing Operations	-1.02	-7.97	-6.60
Consolidated Net Income / (Loss)	-1.02	-7.97	-6.60
Depreciation Expense	11	17	17
Amortization Expense	0.29	0.00	0.00
Non-Cash Adjustments To Reconcile Net Income	14	2.29	5.13
Changes in Operating Assets and Liabilities, net	0.27	-26	35
Net Cash From Investing Activities	80	-11	8.68
Net Cash From Continuing Investing Activities	80	-11	8.68
Purchase of Property, Plant & Equipment	-2.89	-11	-9.77
Divestitures	83	0.00	0.00
Sale and/or Maturity of Investments	0.00	0.00	18
Net Cash From Financing Activities	-50	25	-59
Net Cash From Continuing Financing Activities	-50	25	-59
Repayment of Debt	-126	-226	-306
Payment of Dividends	-8.92	-10	-20
Issuance of Debt	85	261	267
Other Financing Activities, net	-0.67	0.05	0.19
Cash Interest Paid	2.64	2.49	1.48
Cash Income Taxes Paid	2.29	1.49	2.60

This table details how cash moves in and out of Calavo Growers' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Change in Cash & Equivalents	-8.54	56	-3.15	-1.39	2.81	0.69	-2.04	2.40	-1.34	-0.33	0.20
Net Cash From Operating Activities	-4.43	11	11	2.09	0.06	4.73	-15	2.10	-5.88	8.05	21
Net Cash From Continuing Operating Activities	-4.43	11	11	2.09	0.06	4.73	-15	2.10	-5.88	8.05	21
Net Income / (Loss) Continuing Operations	4.44	-0.10	-0.76	6.10	-6.26	-7.92	6.71	-3.96	-2.80	-3.48	1.32
Consolidated Net Income / (Loss)	4.44	-0.10	-0.76	6.10	-6.26	-7.92	6.71	-3.96	-2.80	-3.48	1.32
Depreciation Expense	1.94	1.93	2.04	2.08	4.56	4.47	4.36	4.29	4.17	4.12	4.07
Non-Cash Adjustments To Reconcile Net Income	0.64	-9.57	-3.57	18	9.63	-4.47	-5.25	11	1.07	-12	-20
Changes in Operating Assets and Liabilities, net	-11	18	14	-24	-7.87	13	-21	-9.16	-8.32	19	36
Net Cash From Investing Activities	-0.28	83	-0.14	-1.35	-1.03	-0.60	-1.63	-3.28	-5.19	16	-3.95
Net Cash From Continuing Investing Activities	-0.28	83	-0.14	-1.35	-1.03	-0.60	-1.63	-3.28	-5.19	16	-3.95
Purchase of Property, Plant & Equipment	-0.28	-0.37	-0.14	-1.35	-1.03	-0.60	-1.63	-3.28	-5.19	-2.03	-3.95
Net Cash From Financing Activities	-3.83	-38	-14	-2.13	3.78	-3.44	15	3.58	9.72	-25	-17
Net Cash From Continuing Financing Activities	-3.83	-38	-14	-2.13	3.78	-3.44	15	3.58	9.72	-25	-17
Repayment of Debt	-0.33	-23	-25	-54	-23	-43	-72	-61	-50	-71	-69
Payment of Dividends	-3.57	-3.58	-1.78	-1.78	-1.78	-1.78	-1.78	-1.77	-5.10	-	-
Issuance of Debt	0.11	-10	13	54	29	42	88	66	65	46	53
Other Financing Activities, net	-0.05	-0.04	-	-0.03	-0.60	-	-	-	0.05	0.24	-

This table presents Calavo Growers' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	10/31/2024	10/31/2023	10/31/2022
Total Assets	301	387	386
Total Current Assets	159	133	126
Cash & Equivalents	57	2.09	2.06
Accounts Receivable	42	34	59
Inventories, net	49	46	51
Prepaid Expenses	9.98	12	8.87
Current Deferred & Refundable Income Taxes	0.94	1.09	3.40
Plant, Property, & Equipment, net	54	61	0.00
Total Noncurrent Assets	88	193	260
Long-Term Investments	2.42	2.90	3.78
Goodwill	10	10	29
Noncurrent Deferred & Refundable Income Taxes	7.47	3.01	5.43
Other Noncurrent Operating Assets	68	71	215
Total Liabilities & Shareholders' Equity	301	387	386
Total Liabilities	99	177	162
Total Current Liabilities	73	82	102
Accounts Payable	8.74	5.10	10
Accrued Expenses	28	16	52
Current Deferred & Payable Income Tax Liabilities	2.77	0.00	-
Other Current Liabilities	34	30	40
Total Noncurrent Liabilities	26	95	60
Other Noncurrent Operating Liabilities	26	26	59
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	202	210	223
Total Preferred & Common Equity	200	209	222
Total Common Equity	200	209	222
Common Stock	178	176	171
Retained Earnings	22	32	51
Noncontrolling Interest	1.44	1.39	1.02

This table presents Calavo Growers' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	1/31/2025	7/31/2024	4/30/2024	1/31/2024	7/31/2023	4/30/2023	1/31/2023	7/31/2022
Total Assets	299	382	411	395	415	407	396	431
Total Current Assets	158	238	262	246	150	145	133	148
Cash & Equivalents	48	1.13	4.27	5.66	1.40	4.20	1.80	2.51
Accounts Receivable	47	52	56	35	76	69	62	78
Inventories, net	50	45	53	53	55	56	54	49
Prepaid Expenses	12	8.86	8.19	10	13	11	11	9.22
Current Deferred & Refundable Income Taxes	0.94	3.61	2.06	0.89	4.15	4.33	4.12	8.50
Plant, Property, & Equipment, net	53	56	58	59	114	0.00	116	114
Total Noncurrent Assets	88	88	91	90	150	262	148	168
Long-Term Investments	3.29	2.53	3.11	2.90	3.38	3.88	3.94	25
Goodwill	10	10	10	10	29	29	29	29
Noncurrent Deferred & Refundable Income Taxes	7.47	3.01	3.01	3.01	5.78	5.59	5.43	5.32
Other Noncurrent Operating Assets	67	72	75	73	106	218	103	101
Total Liabilities & Shareholders' Equity	299	382	411	395	415	407	396	431
Total Liabilities	96	177	204	192	196	194	180	205
Total Current Liabilities	71	117	133	121	101	116	105	118
Accounts Payable	6.73	9.82	6.51	4.92	16	19	17	12
Accrued Expenses	30	17	20	21	42	50	52	52
Current Deferred & Payable Income Tax Liabilities	4.12	-	-	-	-	-	-	-
Other Current Liabilities	30	42	53	37	42	45	34	54
Total Noncurrent Liabilities	25	61	71	71	95	78	75	86
Other Noncurrent Operating Liabilities	25	27	25	26	55	51	53	56
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	203	205	207	203	219	213	217	226
Total Preferred & Common Equity	201	204	206	201	218	212	215	225
Total Common Equity	201	204	206	201	218	212	215	225
Common Stock	178	178	177	177	176	175	173	170
Retained Earnings	23	26	29	24	42	37	43	54
Noncontrolling Interest	1.46	1.41	1.44	1.40	1.41	1.32	1.29	1.18

This table displays calculated financial ratios and metrics derived from Calavo Growers' official financial filings.

Metric	2024	2023	2022
Period end date	10/31/2024	10/31/2023	10/31/2022
Growth Metrics	-	-	-
Revenue Growth	11.35%	-22.81%	-27.10%
EBITDA Growth	-28.00%	113.19%	-21.41%
EBIT Growth	-16.77%	796.48%	-297.42%
NOPAT Growth	111.75%	26.18%	-97.47%
Net Income Growth	87.15%	-20.68%	44.62%
EPS Growth	87.23%	-34.29%	47.76%
Operating Cash Flow Growth	268.80%	-128.80%	270.12%
Free Cash Flow Firm Growth	-52.72%	42.20%	-77.59%
Invested Capital Growth	-10.94%	-26.58%	-15.57%
Revenue Q/Q Growth	-34.61%	-14.58%	-36.96%
EBITDA Q/Q Growth	97.92%	0.08%	485.25%
EBIT Q/Q Growth	733.88%	-2.30%	90.49%
NOPAT Q/Q Growth	352.12%	-17.20%	148.80%
Net Income Q/Q Growth	88.42%	-125.69%	59.14%
EPS Q/Q Growth	87.76%	-123.81%	61.11%
Operating Cash Flow Q/Q Growth	33.33%	-29.75%	15.85%
Free Cash Flow Firm Q/Q Growth	-70.55%	463.65%	59.77%
Invested Capital Q/Q Growth	-7.64%	-37.03%	-4.95%
Profitability Metrics	-	-	-
Gross Margin	10.25%	10.54%	7.11%
EBITDA Margin	3.39%	5.24%	1.90%
Operating Margin	2.53%	2.05%	0.88%
EBIT Margin	1.74%	2.33%	-0.26%
Profit (Net Income) Margin	-0.15%	-1.34%	-0.86%
Tax Burden Percent	-10.61%	-65.95%	211.67%
Interest Burden Percent	83.75%	87.25%	156.89%
Effective Tax Rate	24.09%	50.89%	0.00%
Return on Invested Capital (ROIC)	8.40%	3.18%	2.00%
ROIC Less NNEP Spread (ROIC-NNEP)	33.37%	52.92%	-88.11%
Return on Net Nonoperating Assets (RNNOA)	-8.90%	-6.85%	-4.93%
Return on Equity (ROE)	-0.50%	-3.67%	-2.93%
Cash Return on Invested Capital (CROIC)	19.98%	33.83%	18.88%
Operating Return on Assets (OROA)	3.35%	3.58%	-0.48%
Return on Assets (ROA)	-0.30%	-2.06%	-1.59%
Return on Common Equity (ROCE)	-0.49%	-3.65%	-2.92%
Return on Equity Simple (ROE_SIMPLE)	-0.51%	-3.81%	-2.97%
Net Operating Profit after Tax (NOPAT)	13	5.99	4.75
NOPAT Margin	1.92%	1.01%	0.62%
Net Nonoperating Expense Percent (NNEP)	-24.97%	-49.74%	90.11%
Return On Investment Capital (ROIC_SIMPLE)	6.29%	2.40%	2.12%
Cost of Revenue to Revenue	89.75%	89.46%	92.89%
SG&A Expenses to Revenue	7.56%	7.96%	6.05%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	7.72%	8.48%	6.23%
Earnings before Interest and Taxes (EBIT)	12	14	-1.99
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	22	31	15
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	2.34	2.10	2.63
Price to Tangible Book Value (P/TBV)	2.47	2.21	3.14
Price to Revenue (P/Rev)	0.71	0.74	0.76
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	1.90%	2.38%	3.48%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.89	2.96	2.67
Enterprise Value to Revenue (EV/Rev)	0.62	0.80	0.75
Enterprise Value to EBITDA (EV/EBITDA)	18.35	15.19	39.78
Enterprise Value to EBIT (EV/EBIT)	35.68	34.14	0.00
Enterprise Value to NOPAT (EV/NOPAT)	32.39	78.85	122.27
Enterprise Value to Operating Cash Flow (EV/OCF)	16.84	0.00	11.56
Enterprise Value to Free Cash Flow (EV/FCFF)	13.62	7.40	12.94
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.19	0.01
Long-Term Debt to Equity	0.00	0.18	0.01
Financial Leverage	-0.27	-0.13	0.06
Leverage Ratio	1.67	1.78	1.85
Compound Leverage Factor	1.40	1.55	2.90
Debt to Total Capital	0.00%	15.68%	0.53%
Short-Term Debt to Total Capital	0.00%	0.26%	0.00%
Long-Term Debt to Total Capital	0.00%	15.42%	0.53%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.72%	0.56%	0.45%
Common Equity to Total Capital	99.28%	83.76%	99.01%
Debt to EBITDA	0.00	1.26	0.08
Net Debt to EBITDA	0.00	1.07	-0.39
Long-Term Debt to EBITDA	0.00	1.23	0.08
Debt to NOPAT	0.00	6.52	0.25
Net Debt to NOPAT	0.00	5.56	-1.20
Long-Term Debt to NOPAT	0.00	6.41	0.25
Altman Z-Score	5.60	3.42	4.40
Noncontrolling Interest Sharing Ratio	0.69%	0.56%	0.53%
Liquidity Ratios	-	-	-
Current Ratio	2.17	1.63	1.23
Quick Ratio	1.35	0.44	0.60
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	30	64	45
Operating Cash Flow to CapEx	844.95%	-135.27%	514.21%
Free Cash Flow to Firm to Interest Expense	10.43	26.92	27.52
Operating Cash Flow to Interest Expense	8.44	-6.10	30.80
Operating Cash Flow Less CapEx to Interest Expense	7.44	-10.61	24.81
Efficiency Ratios	-	-	-
Asset Turnover	1.92	1.54	1.85
Accounts Receivable Turnover	17.45	12.79	11.16
Inventory Turnover	12.50	10.90	14.49
Fixed Asset Turnover	11.49	0.00	0.00
Accounts Payable Turnover	85.81	68.43	70.68
Days Sales Outstanding (DSO)	20.91	28.54	32.69
Days Inventory Outstanding (DIO)	29.20	33.48	25.20
Days Payable Outstanding (DPO)	4.25	5.33	5.16
Cash Conversion Cycle (CCC)	45.85	56.69	52.73
Capital & Investment Metrics	-	-	-
Invested Capital	142	160	218
Invested Capital Turnover	4.38	3.15	3.24
Increase / (Decrease) in Invested Capital	-17	-58	-40
Enterprise Value (EV)	411	473	581
Market Capitalization	469	438	586
Book Value per Share	$11.25	$11.76	$12.54
Tangible Book Value per Share	$10.68	$11.17	$10.52
Total Capital	202	249	225
Total Debt	0.00	39	1.20
Total Long-Term Debt	0.00	38	1.20
Net Debt	-59	33	-5.72
Capital Expenditures (CapEx)	2.89	11	9.77
Debt-free, Cash-free Net Working Capital (DFCFNWC)	28	49	21
Debt-free Net Working Capital (DFNWC)	85	52	24
Net Working Capital (NWC)	85	52	24
Net Nonoperating Expense (NNE)	14	14	11
Net Nonoperating Obligations (NNO)	-59	-50	-5.72
Total Depreciation and Amortization (D&A)	11	17	17
Debt-free, Cash-free Net Working Capital to Revenue	4.28%	8.32%	2.67%
Debt-free Net Working Capital to Revenue	12.91%	8.80%	3.08%
Net Working Capital to Revenue	12.91%	8.69%	3.08%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.06)	($0.47)	($0.35)
Adjusted Weighted Average Basic Shares Outstanding	17.80M	17.75M	17.66M
Adjusted Diluted Earnings per Share	($0.06)	($0.47)	($0.35)
Adjusted Weighted Average Diluted Shares Outstanding	17.86M	17.75M	17.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.84M	17.80M	17.73M
Normalized Net Operating Profit after Tax (NOPAT)	13	11	5.74
Normalized NOPAT Margin	2.04%	1.81%	0.75%
Pre Tax Income Margin	1.46%	2.03%	-0.41%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	3.98	5.84	-1.22
NOPAT to Interest Expense	4.39	2.53	2.91
EBIT Less CapEx to Interest Expense	2.98	1.33	-7.21
NOPAT Less CapEx to Interest Expense	3.39	-1.98	-3.08
Payout Ratios	-	-	-
Dividend Payout Ratio	-871.19%	-130.95%	-307.94%
Augmented Payout Ratio	-871.19%	-130.95%	-307.94%

This table displays calculated financial ratios and metrics derived from Calavo Growers' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	20.99%	19.52%	11.65%	16.49%	-3.88%	179.98%	-52.96%	-52.24%	-51.56%	-165.03%	19.99%
EBITDA Growth	81.76%	-58.38%	-56.01%	49.32%	-13.43%	11.65%	135.48%	59.05%	2,771.92%	123.73%	52.37%
EBIT Growth	456.20%	45.37%	-57.00%	243.12%	-344.53%	10.34%	306.19%	44,520.00%	94.06%	96.98%	2,445.83%
NOPAT Growth	272.87%	-1,844.43%	52.49%	361.69%	-410.08%	-82.28%	745.79%	-52.82%	79.75%	122.60%	123.56%
Net Income Growth	170.88%	98.69%	-111.36%	254.02%	-123.86%	-127.39%	409.34%	-1,334.78%	32.81%	73.29%	110.20%
EPS Growth	171.43%	97.73%	-110.81%	247.83%	-105.88%	-144.44%	428.57%	-2,200.00%	26.09%	75.34%	109.46%
Operating Cash Flow Growth	-7,732.76%	128.99%	174.14%	-0.29%	100.99%	-41.21%	-173.95%	-88.93%	-346.06%	584.44%	956.87%
Free Cash Flow Firm Growth	-88.32%	-84.16%	771.09%	550.19%	244.69%	36.22%	-143.04%	-68.05%	224.56%	4,078.05%	2,585.70%
Invested Capital Growth	-3.27%	-10.94%	-39.28%	-31.52%	-33.28%	-26.58%	10.83%	-4.46%	-8.73%	-15.57%	-14.18%
Revenue Q/Q Growth	-9.16%	-5.37%	-2.60%	44.49%	-10.27%	-11.60%	1.63%	19.22%	-45.49%	-151.99%	3.19%
EBITDA Q/Q Growth	274.50%	-77.79%	-24.20%	188.21%	-14.25%	-76.52%	157.30%	67.09%	-0.33%	-50.48%	73.79%
EBIT Q/Q Growth	1,551.90%	-105.42%	-30.29%	749.83%	-122.68%	-104.26%	456.21%	941.89%	-30.54%	-119.31%	61,000.00%
NOPAT Q/Q Growth	145.24%	-166.82%	83.84%	796.58%	-556.51%	-94.16%	456.62%	443.65%	-120.07%	178.82%	-68.95%
Net Income Q/Q Growth	4,364.42%	86.35%	-112.49%	197.47%	21.00%	-218.07%	269.39%	-41.68%	19.75%	-364.46%	577.17%
EPS Q/Q Growth	2,600.00%	75.00%	-111.76%	197.14%	20.45%	-218.92%	260.87%	-35.29%	5.56%	-357.14%	800.00%
Operating Cash Flow Q/Q Growth	-140.85%	-5.22%	446.51%	3,506.90%	-98.77%	130.69%	-834.99%	135.70%	-173.00%	-61.40%	10.07%
Free Cash Flow Firm Q/Q Growth	-4.21%	-91.76%	39.29%	4.53%	29.89%	449.33%	-234.95%	-43.71%	-47.99%	10.36%	0.18%
Invested Capital Q/Q Growth	6.16%	-7.64%	-3.77%	2.51%	-2.26%	-37.03%	8.53%	-0.12%	7.56%	-4.95%	-6.44%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	10.19%	8.76%	11.19%	11.04%	8.43%	8.33%	13.68%	9.90%	9.86%	0.00%	5.41%
EBITDA Margin	3.98%	0.96%	4.11%	5.28%	2.65%	2.77%	10.43%	4.12%	2.94%	0.00%	2.08%
Operating Margin	3.27%	0.95%	5.21%	3.87%	-2.42%	0.48%	6.35%	1.22%	-0.46%	0.00%	0.45%
EBIT Margin	2.72%	-0.17%	2.97%	4.15%	-0.92%	-0.37%	7.71%	1.41%	-0.20%	0.00%	0.89%
Profit (Net Income) Margin	2.87%	-0.06%	-0.42%	3.31%	-4.90%	-5.57%	4.17%	-2.50%	-2.11%	0.00%	0.39%
Tax Burden Percent	91.86%	-22.76%	-16.92%	91.13%	312.54%	872.25%	57.61%	-199.30%	435.36%	775.72%	51.25%
Interest Burden Percent	115.06%	-158.13%	84.39%	87.43%	169.95%	171.64%	93.83%	89.06%	242.26%	76.10%	84.12%
Effective Tax Rate	25.99%	613.35%	-32.00%	5.83%	0.00%	0.00%	20.68%	24.36%	0.00%	0.00%	38.29%
Return on Invested Capital (ROIC)	10.84%	-21.27%	34.12%	18.37%	-5.11%	1.05%	14.51%	3.37%	-1.37%	0.00%	1.38%
ROIC Less NNEP Spread (ROIC-NNEP)	9.41%	-36.11%	194.10%	23.04%	23.16%	30.95%	7.15%	-22.64%	-10.74%	0.00%	8.14%
Return on Net Nonoperating Assets (RNNOA)	-2.28%	9.63%	-7.50%	-1.45%	-1.60%	-4.01%	0.61%	-2.16%	-1.23%	0.00%	0.18%
Return on Equity (ROE)	8.56%	-11.64%	26.62%	16.91%	-6.71%	-2.96%	15.12%	1.21%	-2.60%	0.00%	1.56%
Cash Return on Invested Capital (CROIC)	16.55%	19.98%	50.25%	32.63%	41.76%	33.83%	-7.27%	3.76%	1.55%	18.88%	11.33%
Operating Return on Assets (OROA)	5.39%	-0.33%	7.54%	10.07%	-1.37%	-0.57%	12.69%	2.82%	-0.48%	0.00%	2.45%
Return on Assets (ROA)	5.70%	-0.12%	-1.08%	8.02%	-7.30%	-8.57%	6.86%	-5.01%	-5.11%	0.00%	1.06%
Return on Common Equity (ROCE)	8.50%	-11.56%	26.44%	16.80%	-6.67%	-2.94%	15.03%	1.20%	-2.58%	0.00%	1.55%
Return on Equity Simple (ROE_SIMPLE)	4.80%	0.00%	-4.34%	-0.67%	-5.68%	0.00%	-1.62%	-4.21%	-2.43%	0.00%	-7.19%
Net Operating Profit after Tax (NOPAT)	3.73	-8.25	12	6.72	-2.16	0.47	8.10	1.46	-0.42	2.67	0.96
NOPAT Margin	2.42%	-4.86%	6.88%	3.64%	-1.69%	0.33%	5.04%	0.92%	-0.32%	0.00%	0.28%
Net Nonoperating Expense Percent (NNEP)	1.43%	14.84%	-159.98%	-4.67%	-28.27%	-29.90%	7.36%	26.01%	9.38%	48.84%	-6.76%
Return On Investment Capital (ROIC_SIMPLE)	1.84%	-4.09%	-	-	-0.87%	0.19%	-	-	-	1.19%	-
Cost of Revenue to Revenue	89.81%	91.24%	88.81%	88.96%	91.57%	91.67%	86.32%	90.10%	90.14%	0.00%	94.59%
SG&A Expenses to Revenue	6.66%	7.68%	5.85%	7.06%	10.55%	6.53%	8.08%	8.44%	8.77%	0.00%	4.87%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	6.92%	7.81%	5.98%	7.17%	10.85%	7.86%	7.33%	8.69%	10.31%	0.00%	4.96%
Earnings before Interest and Taxes (EBIT)	4.20	-0.29	5.34	7.66	-1.18	-0.53	12	2.23	-0.27	-0.59	3.06
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6.14	1.64	7.38	9.73	3.38	3.94	17	6.52	3.90	3.53	7.12
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.03	2.34	2.08	2.32	2.25	2.10	3.03	2.63	2.58	2.63	3.09
Price to Tangible Book Value (P/TBV)	2.14	2.47	2.19	2.44	2.37	2.21	3.61	3.15	3.09	3.14	3.68
Price to Revenue (P/Rev)	0.59	0.71	0.42	0.48	0.77	0.74	0.95	0.63	0.53	0.76	0.57
Price to Earnings (P/E)	42.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	3.06%	1.90%	1.68%	1.49%	1.57%	2.38%	1.31%	1.24%	0.92%	3.48%	2.94%
Earnings Yield	2.35%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.37	2.89	2.95	3.23	3.14	2.96	2.75	2.47	2.45	2.67	3.05
Enterprise Value to Revenue (EV/Rev)	0.52	0.62	0.45	0.52	0.83	0.80	1.00	0.66	0.55	0.75	0.57
Enterprise Value to EBITDA (EV/EBITDA)	14.38	18.35	40.16	24.98	16.05	15.19	22.40	26.96	30.16	39.78	0.00
Enterprise Value to EBIT (EV/EBIT)	21.19	35.68	0.00	98.47	37.98	34.14	49.16	120.07	221.50	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	17.62	32.39	161.97	0.00	136.76	78.85	96.23	0.00	0.00	122.27	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	17.96	16.84	24.83	0.00	0.00	0.00	0.00	23.03	13.68	11.56	16.09
Enterprise Value to Free Cash Flow (EV/FCFF)	14.08	13.62	4.44	8.05	6.03	7.40	0.00	64.36	151.16	12.94	24.83
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.16	0.22	0.23	0.19	0.18	0.13	0.11	0.01	0.14
Long-Term Debt to Equity	0.00	0.00	0.16	0.22	0.22	0.18	0.18	0.13	0.10	0.01	0.13
Financial Leverage	-0.24	-0.27	-0.04	-0.06	-0.07	-0.13	0.09	0.10	0.11	0.06	0.02
Leverage Ratio	1.71	1.67	1.88	1.95	1.89	1.78	1.90	2.00	1.97	1.85	1.83
Compound Leverage Factor	1.97	-2.64	1.59	1.70	3.21	3.06	1.78	1.78	4.76	1.40	1.54
Debt to Total Capital	0.00%	0.00%	14.05%	18.11%	18.40%	15.68%	15.51%	11.88%	9.62%	0.53%	12.21%
Short-Term Debt to Total Capital	0.00%	0.00%	0.34%	0.32%	0.32%	0.26%	0.16%	0.70%	0.72%	0.00%	0.59%
Long-Term Debt to Total Capital	0.00%	0.00%	13.71%	17.79%	18.09%	15.42%	15.36%	11.18%	8.90%	0.53%	11.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.72%	0.72%	0.59%	0.57%	0.56%	0.56%	0.54%	0.55%	0.54%	0.45%	0.46%
Common Equity to Total Capital	99.28%	99.28%	85.36%	81.32%	81.03%	83.76%	83.95%	87.58%	89.84%	99.01%	87.33%
Debt to EBITDA	0.00	0.00	2.96	2.21	1.49	1.26	1.29	1.34	1.21	0.08	-8.28
Net Debt to EBITDA	0.00	0.00	2.64	1.86	1.21	1.07	1.12	0.96	0.91	-0.39	-0.83
Long-Term Debt to EBITDA	0.00	0.00	2.89	2.17	1.47	1.23	1.28	1.26	1.12	0.08	-7.88
Debt to NOPAT	0.00	0.00	11.94	-4.86	12.72	6.52	5.56	-14.92	-1.24	0.25	-3.23
Net Debt to NOPAT	0.00	0.00	10.64	-4.08	10.34	5.56	4.79	-10.72	-0.93	-1.20	-0.32
Long-Term Debt to NOPAT	0.00	0.00	11.65	-4.78	12.50	6.41	5.50	-14.04	-1.15	0.25	-3.07
Altman Z-Score	5.36	5.47	4.60	4.35	3.36	3.30	4.08	4.11	4.74	4.41	5.15
Noncontrolling Interest Sharing Ratio	0.71%	0.69%	0.66%	0.66%	0.64%	0.56%	0.58%	0.57%	0.58%	0.00%	0.54%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.23	2.17	2.04	1.97	2.03	1.63	1.48	1.25	1.26	1.23	1.25
Quick Ratio	1.35	1.35	0.45	0.45	0.34	0.44	0.77	0.63	0.61	0.60	0.68
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	8.85	9.24	112	80	76	58	-17	12	22	43	39
Operating Cash Flow to CapEx	-1,569.86%	2,920.75%	8,051.41%	155.31%	5.63%	786.05%	-945.43%	64.04%	-113.33%	396.31%	527.77%
Free Cash Flow to Firm to Interest Expense	41.53	33.71	134.49	83.61	91.93	59.27	-21.79	50.70	58.29	119.25	79.98
Operating Cash Flow to Interest Expense	-20.78	39.55	13.73	2.17	0.07	4.81	-20.13	8.60	-15.59	22.42	42.99
Operating Cash Flow Less CapEx to Interest Expense	-22.11	38.19	13.55	0.77	-1.18	4.20	-22.26	-4.83	-29.34	16.76	34.85
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.98	1.92	2.54	2.43	1.49	1.54	1.65	2.00	2.43	1.85	2.74
Accounts Receivable Turnover	16.74	17.45	15.77	15.89	12.09	12.79	8.98	10.19	13.84	11.16	15.41
Inventory Turnover	11.94	12.50	18.91	16.88	9.90	10.90	12.07	13.76	16.80	14.49	22.08
Fixed Asset Turnover	12.32	11.49	11.89	0.00	6.73	0.00	6.08	0.00	9.06	0.00	0.00
Accounts Payable Turnover	105.76	85.81	71.60	71.56	47.33	68.43	44.63	42.79	66.69	70.68	105.42
Days Sales Outstanding (DSO)	21.81	20.91	23.14	22.97	30.18	28.54	40.65	35.80	26.37	32.69	23.69
Days Inventory Outstanding (DIO)	30.57	29.20	19.30	21.62	36.87	33.48	30.25	26.53	21.73	25.20	16.53
Days Payable Outstanding (DPO)	3.45	4.25	5.10	5.10	7.71	5.33	8.18	8.53	5.47	5.16	3.46
Cash Conversion Cycle (CCC)	48.92	45.85	37.34	39.49	59.34	56.69	62.72	53.81	42.63	52.73	36.76
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	151	142	154	160	156	160	254	234	234	218	229
Invested Capital Turnover	4.48	4.38	4.96	5.04	3.02	3.15	2.88	3.66	4.28	3.24	4.93
Increase / (Decrease) in Invested Capital	-5.11	-17	-100	-74	-78	-58	25	-11	-22	-40	-38
Enterprise Value (EV)	358	411	455	517	491	473	697	579	574	581	698
Market Capitalization	408	469	423	478	453	438	661	557	556	586	693
Book Value per Share	$11.29	$11.25	$11.45	$11.57	$11.32	$11.76	$12.24	$11.94	$12.15	$12.54	$12.66
Tangible Book Value per Share	$10.72	$10.68	$10.86	$10.98	$10.73	$11.17	$10.29	$9.96	$10.15	$10.52	$10.62
Total Capital	203	202	239	253	248	249	259	242	240	225	257
Total Debt	0.00	0.00	34	46	46	39	40	29	23	1.20	31
Total Long-Term Debt	0.00	0.00	33	45	45	38	40	27	21	1.20	30
Net Debt	-52	-59	30	38	37	33	35	21	17	-5.72	3.15
Capital Expenditures (CapEx)	0.28	0.37	0.14	1.35	1.03	0.60	1.63	3.28	5.19	2.03	3.95
Debt-free, Cash-free Net Working Capital (DFCFNWC)	39	28	121	126	120	49	47	26	28	21	28
Debt-free Net Working Capital (DFNWC)	87	85	123	130	125	52	49	31	30	24	32
Net Working Capital (NWC)	87	85	122	129	125	52	49	29	28	24	30
Net Nonoperating Expense (NNE)	-0.70	-8.15	13	0.62	4.10	8.39	1.39	5.42	2.37	6.15	-0.36
Net Nonoperating Obligations (NNO)	-52	-59	-51	-47	-46	-50	35	21	17	-5.72	3.15
Total Depreciation and Amortization (D&A)	1.94	1.93	2.04	2.08	4.56	4.47	4.36	4.29	4.17	4.12	4.07
Debt-free, Cash-free Net Working Capital to Revenue	5.65%	4.28%	12.00%	12.66%	20.35%	8.32%	6.80%	3.02%	2.64%	2.67%	2.30%
Debt-free Net Working Capital to Revenue	12.69%	12.91%	12.11%	13.09%	21.31%	8.80%	7.11%	3.50%	2.81%	3.08%	2.58%
Net Working Capital to Revenue	12.69%	12.91%	12.03%	13.01%	21.17%	8.69%	7.05%	3.30%	2.65%	3.08%	2.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.25	($0.01)	($0.04)	$0.34	($0.35)	($0.44)	$0.37	($0.23)	($0.17)	($0.18)	$0.07
Adjusted Weighted Average Basic Shares Outstanding	17.84M	17.80M	17.80M	17.80M	17.80M	17.75M	17.76M	17.72M	17.67M	17.66M	17.67M
Adjusted Diluted Earnings per Share	$0.25	($0.01)	($0.04)	$0.34	($0.35)	($0.44)	$0.37	($0.23)	($0.17)	($0.18)	$0.07
Adjusted Weighted Average Diluted Shares Outstanding	17.90M	17.86M	17.84M	17.87M	17.80M	17.85M	17.86M	17.72M	17.67M	17.75M	17.77M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.84M	17.84M	17.80M	17.80M	17.80M	17.80M	17.76M	17.78M	17.74M	17.73M	17.73M
Normalized Net Operating Profit after Tax (NOPAT)	4.03	1.13	6.55	6.91	-1.89	1.80	7.15	1.75	1.01	2.86	1.14
Normalized NOPAT Margin	2.61%	0.66%	3.65%	3.75%	-1.48%	1.27%	4.44%	1.10%	0.76%	0.00%	0.33%
Pre Tax Income Margin	3.13%	0.27%	2.51%	3.63%	-1.57%	-0.64%	7.24%	1.26%	-0.48%	0.00%	0.75%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	19.70	-1.05	6.41	7.96	-1.43	-0.54	16.20	9.14	-0.70	-1.64	6.30
NOPAT to Interest Expense	17.53	-30.13	14.83	6.98	-2.62	0.48	10.58	5.96	-1.12	7.44	1.97
EBIT Less CapEx to Interest Expense	18.38	-2.41	6.24	6.56	-2.68	-1.15	14.07	-4.28	-14.46	-7.30	-1.85
NOPAT Less CapEx to Interest Expense	16.21	-31.48	14.66	5.58	-3.87	-0.13	8.45	-7.46	-14.88	1.78	-6.17
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	110.75%	-871.19%	-80.54%	-519.56%	-62.23%	-130.95%	-245.16%	-77.08%	-97.42%	-307.94%	-125.83%
Augmented Payout Ratio	110.75%	-871.19%	-80.54%	-519.56%	-62.23%	-130.95%	-245.16%	-77.08%	-97.42%	-307.94%	-125.83%

Frequently Asked Questions About Calavo Growers' Financials

When does Calavo Growers's fiscal year end?

According to the most recent income statement we have on file, Calavo Growers' financial year ends in October. Their financial year 2024 ended on October 31, 2024.

How has Calavo Growers' net income changed over the last 2 years?

Calavo Growers' net income appears to be on a downward trend, with a most recent value of -$1.02 million in 2024, falling from -$6.60 million in 2022. The previous period was -$7.97 million in 2023. View Calavo Growers' forecast to see where analysts expect Calavo Growers to go next.

What is Calavo Growers's operating income?

Calavo Growers's total operating income in 2024 was $16.72 million, based on the following breakdown:

Total Gross Profit: $67.80 million
Total Operating Expenses: $51.08 million

How has Calavo Growers revenue changed over the last 2 years?

Over the last 2 years, Calavo Growers' total revenue changed from $769.69 million in 2022 to $661.54 million in 2024, a change of -14.1%.

How much debt does Calavo Growers have?

Calavo Growers' total liabilities were at $99.34 million at the end of 2024, a 43.8% decrease from 2023, and a 38.8% decrease since 2022.

How much cash does Calavo Growers have?

In the past 2 years, Calavo Growers' cash and equivalents has ranged from $2.06 million in 2022 to $57.03 million in 2024, and is currently $57.03 million as of their latest financial filing in 2024.

How has Calavo Growers' book value per share changed over the last 2 years?

Over the last 2 years, Calavo Growers' book value per share changed from 12.54 in 2022 to 11.25 in 2024, a change of -10.3%.

Related Companies

This page (NASDAQ:CVGW) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Calavo Growers (CVGW) Financials

Frequently Asked Questions About Calavo Growers' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Calavo Growers (CVGW) Financials

Annual Income Statements for Calavo Growers

Quarterly Income Statements for Calavo Growers

Annual Cash Flow Statements for Calavo Growers

Quarterly Cash Flow Statements for Calavo Growers

Annual Balance Sheets for Calavo Growers

Quarterly Balance Sheets for Calavo Growers

Annual Metrics And Ratios for Calavo Growers

Quarterly Metrics And Ratios for Calavo Growers

Frequently Asked Questions About Calavo Growers' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools